LV12658B - Sausa aktivas vielas pulvera ievadisanas panemiens plausas - Google Patents

Sausa aktivas vielas pulvera ievadisanas panemiens plausas

Info

Publication number
LV12658B
LV12658B LV010041A LV010041A LV12658B LV 12658 B LV12658 B LV 12658B LV 010041 A LV010041 A LV 010041A LV 010041 A LV010041 A LV 010041A LV 12658 B LV12658 B LV 12658B
Authority
LV
Latvia
Prior art keywords
pancake
powders
active substance
powder injection
substance powder
Prior art date
Application number
LV010041A
Other languages
English (en)
Latvian (lv)
Other versions
LV12658A (lv
Inventor
Andrew Clark
Mei-Chang Kuo
Cecily Lalor
Barry John Aldous
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of LV12658A publication Critical patent/LV12658A/xx
Publication of LV12658B publication Critical patent/LV12658B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
LV010041A 1998-09-14 2001-03-14 Sausa aktivas vielas pulvera ievadisanas panemiens plausas LV12658B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (2)

Publication Number Publication Date
LV12658A LV12658A (lv) 2001-05-20
LV12658B true LV12658B (lv) 2001-09-20

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
LV010041A LV12658B (lv) 1998-09-14 2001-03-14 Sausa aktivas vielas pulvera ievadisanas panemiens plausas

Country Status (44)

Country Link
EP (1) EP1117442A1 (is)
JP (1) JP2002524535A (is)
KR (1) KR20010075063A (is)
CN (1) CN1317977A (is)
AP (1) AP1374A (is)
AR (1) AR022090A1 (is)
AU (1) AU753014B2 (is)
BG (1) BG105430A (is)
BR (1) BR9913722A (is)
CA (1) CA2343920A1 (is)
CO (1) CO5130023A1 (is)
CZ (1) CZ2001829A3 (is)
DZ (1) DZ2892A1 (is)
EA (1) EA003476B1 (is)
EE (1) EE200100151A (is)
GE (1) GEP20043257B (is)
GT (1) GT199900156A (is)
HK (1) HK1042231A1 (is)
HN (1) HN1999000159A (is)
HR (1) HRP20010189A2 (is)
HU (1) HUP0103837A3 (is)
ID (1) ID28845A (is)
IL (2) IL141562A0 (is)
IS (1) IS5878A (is)
LT (1) LT4897B (is)
LV (1) LV12658B (is)
MA (1) MA25590A1 (is)
MY (1) MY129282A (is)
NO (1) NO20011251L (is)
NZ (1) NZ510168A (is)
OA (1) OA11781A (is)
PA (1) PA8481901A1 (is)
PE (1) PE20001061A1 (is)
PL (1) PL195574B1 (is)
SA (1) SA99200718B1 (is)
SK (1) SK3442001A3 (is)
TN (1) TNSN99173A1 (is)
TR (1) TR200101182T2 (is)
TW (1) TWI226248B (is)
UA (1) UA76085C2 (is)
UY (1) UY25711A1 (is)
WO (1) WO2000015262A1 (is)
YU (1) YU24201A (is)
ZA (1) ZA200101995B (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198593C (zh) 1999-06-09 2005-04-27 罗伯特·E·希弗斯 超临界流体辅助的喷雾和鼓泡干燥
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
EP1392262A1 (en) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CN1671643B (zh) 2002-02-25 2013-05-29 扩散药品有限公司 双极性反式类胡萝卜素盐及其应用
WO2004004798A2 (en) * 2002-07-03 2004-01-15 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
MXPA05006802A (es) * 2002-12-19 2005-09-08 Pharmacia Corp Formulacion no higroscopica que comprende un farmaco higroscopico.
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
MXPA06012240A (es) 2004-04-23 2007-01-31 Cydex Inc Formulacion para inhalador de polvo seco que contiene eter sulfoalquilico-ciclodextrina.
EP2540696B1 (en) * 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
KR20070110418A (ko) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 입자 및 그 입자를 함유하는 제제
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
MX348982B (es) 2005-10-26 2017-07-06 Cydex Pharmaceuticals Inc Composiciones de eter sulfoalquilico-ciclodextrina y metodos de preparacion de las mismas.
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
US20100093875A1 (en) * 2006-10-25 2010-04-15 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
EP3483140A1 (en) 2007-04-13 2019-05-15 Diffusion Pharmaceuticals LLC Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
CN101878040A (zh) 2007-10-31 2010-11-03 扩散药品有限公司 一类促进小分子扩散的新型治疗剂
US9610343B2 (en) * 2009-05-20 2017-04-04 Aeras Global Tb Vaccine Foundation Stable, spray dryed, immunogenic, viral compositions
CN108464976A (zh) 2009-06-22 2018-08-31 扩散药品有限公司 扩散促进化合物及其单独或与溶栓药一起的应用
US8974822B2 (en) 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
JP6349304B2 (ja) 2012-05-03 2018-06-27 ヤンセン・サイエンシズ・アイルランド・ユーシー 上気道感染症の処置のためのポリイノシン−ポリシチジル酸（ポリ（ｉ：ｃ））製剤
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
WO2015042352A1 (en) * 2013-09-20 2015-03-26 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
KR102489034B1 (ko) 2016-03-24 2023-01-13 디퓨젼 파마슈티컬즈 엘엘씨 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
WO1993025198A1 (en) * 1992-06-12 1993-12-23 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
NZ510168A (en) 2003-09-26
WO2000015262A1 (en) 2000-03-23
EA003476B1 (ru) 2003-06-26
LV12658A (lv) 2001-05-20
IL141562A (en) 2007-07-24
EA200100300A1 (ru) 2001-10-22
AP1374A (en) 2005-02-28
KR20010075063A (ko) 2001-08-09
TNSN99173A1 (fr) 2005-11-10
ID28845A (id) 2001-07-05
OA11781A (en) 2005-07-26
BG105430A (en) 2001-12-29
HK1042231A1 (zh) 2002-08-09
TR200101182T2 (tr) 2001-09-21
AR022090A1 (es) 2002-09-04
UA76085C2 (en) 2006-07-17
EE200100151A (et) 2002-06-17
AP2001002093A0 (en) 2001-03-31
SK3442001A3 (en) 2001-11-06
BR9913722A (pt) 2001-05-29
HN1999000159A (es) 1999-11-11
CZ2001829A3 (cs) 2001-09-12
HRP20010189A2 (en) 2005-04-30
MY129282A (en) 2007-03-30
YU24201A (sh) 2003-08-29
EP1117442A1 (en) 2001-07-25
DZ2892A1 (fr) 2003-12-15
GEP20043257B (en) 2004-06-25
CA2343920A1 (en) 2000-03-23
AU753014B2 (en) 2002-10-03
IL141562A0 (en) 2002-03-10
PL346768A1 (en) 2002-02-25
TWI226248B (en) 2005-01-11
LT4897B (lt) 2002-02-25
PE20001061A1 (es) 2000-10-08
PL195574B1 (pl) 2007-10-31
MA25590A1 (fr) 2002-12-31
AU6039799A (en) 2000-04-03
CN1317977A (zh) 2001-10-17
NO20011251D0 (no) 2001-03-13
GT199900156A (es) 2001-03-07
CO5130023A1 (es) 2002-02-27
ZA200101995B (en) 2002-03-11
SA99200718B1 (ar) 2006-11-04
PA8481901A1 (es) 2002-04-25
LT2001021A (en) 2001-11-26
HUP0103837A3 (en) 2002-11-28
IS5878A (is) 2001-03-05
UY25711A1 (es) 1999-11-17
HUP0103837A2 (hu) 2002-05-29
JP2002524535A (ja) 2002-08-06
NO20011251L (no) 2001-04-17

Similar Documents

Publication Publication Date Title
LV12658B (lv) Sausa aktivas vielas pulvera ievadisanas panemiens plausas
DE60035911D1 (de) Trockenpulverinhalator
HUP0001799A3 (en) Dry powder inhaler
IS4364A (is) Innöndunarbúnaður fyrir þurrduft
EP0927025A4 (en) DRY POWDER COMPOSITION WITH ACTIVE INGREDIENT ENCLOSED IN LIPOSOMES
FI954098A (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
DE69428743D1 (de) Trockenpulverinhalator
ATE460955T1 (de) Trockenpulver-inhalator
EP1307256A4 (en) dry powder inhaler
DE60023254D1 (de) Kosmetische Kompaktpuder Zusammensetzung
HK1045817A1 (en) Texture masked particles containing an active ingredient
NO994519L (no) Fremstilling av pulveragglomerater
NO990272D0 (no) Pulver-inhalator
HUP0104483A3 (en) Fungicidal active substance combinations and use thereof
DE69926719D1 (de) Nickel-metallpulver
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
ID18341A (id) Komposisi-komposisi keju berbubuk kering
GB9916316D0 (en) Dry powder compositions
ID23192A (id) Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol
GB0003935D0 (en) Formulation for dry powder inhaler
PL349862A1 (en) Fungicidal active substance combinations
DE60123539D1 (de) Puderquaste
GB9719093D0 (en) Improvements to dry powder inhalers
HK1040882A1 (zh) 殺菌活性物質組合物
AU1752601A (en) Dry powder inhaler